CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival

Journal of Clinical Investigation

Volumn 99, Issue 3, 1997, Pages 396-402

  Stuart, P Michael ^a   Griffith, Thomas S ^a   Usui, Norio ^a   Pepose, Jay ^a   Yu, Xinhong ^a   Ferguson, Thomas A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death; Fas ligand; Immune privilege; Keratoplasty; Transplantation

Indexed keywords

FAS ANTIGEN;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; CELL KILLING; CONTROLLED STUDY; CORNEA TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KERATOPLASTY; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030821649     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119173     Document Type: Article

References (27)

1. Brady, S.E., J.C. Rapuano, J.J. Arentsen, E.J. Cohen, and P.R. Laibson. 1989. Clinical indications and procedures associated with penetrating keratoplasty. Am. J. Ophthalmol. 108:118-122.
2. Vail, A., S.M. Gore, B.A. Bradley, D.L. Easty, and C.A. Rogers. 1993. Corneal transplant follow-up study. Invest. Ophthalmol. Vis. Sci. 34A:1366.
3. Council on Scientific Affairs. 1988. Report of the Organ Transplant Panel: Corneal Transplantation. JAMA (J. Am. Med. Assoc.). 259:719-722.
4. Joo, C.-K., J.S. Pepose, and P.M. Stuart. 1995. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest. Ophthalmol. Vis. Sci. 36:1530-1540.
5. Joo, C-K., J.S. Pepose, K.A. Laycock, and P.M. Stuart. 1994. Allogeneic graft rejection in a murine model of orthotopic corneal transplantation. In Advances in Ocular Immunology. R.B. Nussenblatt, S.M. Whitcup, R.R. Caspi, and I. Gery, editors. Elsevier Science B.V., Amsterdam, The Netherlands. 115-118.
6. Sonoda, Y., and J.W. Streilein. 1993. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J. Immunol. 150:1727-1734.
7. Niederkorn, J. Y., D. Callahan, and J.R. Ross. 1990. Prevention of the induction of allospecific cytotoxic T lymphocyte and delayed hypersensitivity responses by ultraviolet irradiation of corneal allografts. Transplantation (Baltimore). 50:281-286.
8. Goldberg, M., T. A. Ferguson, and J.S. Pepose. 1994. Detection of cellular adhesion molecules in inflamed human corneas. Ophthalmology. 101:161.
9. Griffith, T.S., T. Brunner, S.M. Fletcher, D.R. Green, and T.A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science (Wash. DC). 270:1189-1192.
10. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R.C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature (Lond.). 377:630-632.
11. Griffith, T.S., X. Yu, J.M. Herndon, D.R. Green, and T.A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 5:7-16.
12. Singer, G.G., and A.K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:365-371.
13. Mogil, R.J., L. Radvanyi, R. Gonzalez-Quintial, R. Miller, G. Mills, A.N. Theofilopoulos, and D.R. Green. 1995. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 7:1451-1458.
14. Ju, S.-T., D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (Lond.). 373: 444-448.
15. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16:39-43.
16. Rieux-Laucat, F. F. LeDeist, C. Hivoz, A.G. Roberts, K.M. Debatin, A. Fischer, and J.P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (Wash. DC). 268: 1347-1349.
17. Abbas, A.K. 1996. Die and let live: eliminating dangerous lymphocytes. Cell. 84:655-657.
18. Lau, H.T., M. Yu, A. Fontana, and C.J. Stoeckert, Jr. 1996. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science (Wash. DC). 273:109-112.
19. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.). 373:441-444.
20. Stuart, P.M., R.W. Melvold, and B. Beck-Maier. 1984. Provocation of skin graft rejection across murine class II differences by non-bone marrow derived cells. Transplantation (Baltimore). 37:393-396.
21. Ferguson, T.A., S. Fletcher, J.M. Herndon, and T.S. Griffith. 1995. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J. Immunol. 155:1746-1756.
22. Wilbanks, G., M. Mammolenti, and J.W. Streilein. 1991. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J. Immunol. 146:3018-3024.
23. Kaplan, H.J., and J.W. Streilein. 1977. Immune response to immunization via the anterior chamber of the eye. I. F1 lymphocyte-induced immune deviation. J. Immunol. 118:809-814.
24. Ferguson, T.A., J. Hayashi, and H.J. Kaplan. 1989. The immune response and the eye. III. Anterior chamber associated immune deviation can be adoptively transferred by serum. J. Immunol. 143:821-826.
25. Griffith, T.S., J.M. Herndon, J. Lima, M. Kahn, and T.A. Ferguson. 1995. The immune response and the eye. T-cell receptor α-chain related molecules regulate the systemic immunity to antigen presented via the anterior chamber of the eye. Int. Immunol. 7:1617-1625.
26. Ferguson, T.A., P. Dube, and T.S. Griffith. 1994. Regulation of contact hypersensitivity by IL-10. J. Exp. Med. 179:1597-1603.
27. Boisjoly, H.M., R. Taourigny, R. Bazin, P.A. Laughrea, I. Dube, G. Chamberland, J. Bernier, and R. Roy. 1993. Risk factors of corneal graft failure. Ophthalmology. 100:1728-1735.